D-cycloserine: A Novel Treatment for Gulf War Illness (GWDCS)

Clinical trial NCT02983734 · UNKNOWN

Trial details

NCT number: NCT02983734
Sponsor: Boston University Charles River Campus
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gulf War Illness

Start date: 2015-10-01
Primary completion: 2019-09-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.